Evidence map›Paper›PMID 25918347›Full record

ArticleBlood2015

Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies.

Sachiko Seo, Christian Renaud, Jane M Kuypers, Charles Y Chiu, Meei-Li Huang, Erik Samayoa, Hu Xie, Guixia Yu, Cynthia E Fisher, Ted A Gooley and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 2 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 2 syntheses or guidelines pooled it, 178 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2018
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Targeted lungScience advances · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Review
  17. Review
  18. Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Sachiko SeoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
Christian RenaudDepartment of Microbiology and Immunology, University of Montreal, Montreal, Canada;
Jane M KuypersVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Laboratory Medicine, University of Washington, Seattle, WA;
Charles Y ChiuDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA;
Meei-Li HuangVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Laboratory Medicine, University of Washington, Seattle, WA;
Erik SamayoaDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA;
Hu XieClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
Guixia YuDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA;
Cynthia E FisherVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Medicine, and.
Ted A GooleyClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
Steven MillerDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA;
Robert C HackmanVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Laboratory Medicine, University of Washington, Seattle, WA; Department of Pathology, University of Washington, Seattle, WA;
David MyersonClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Pathology, University of Washington, Seattle, WA;
Ruth H SedlakDepartment of Laboratory Medicine, University of Washington, Seattle, WA;
Yae-Jean KimDepartment of Pediatrics, Samsung Medical Center, Sungkyungkwan University, School of Medicine, Seoul, Korea; and.
Takahiro FukudaHematopoietic Stem Cell Transplantation Division, National Cancer Research Center Hospital, Tokyo, Japan.
David N FredricksVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Medicine, and.
David K MadtesClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Medicine, and.
Keith R JeromeVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Laboratory Medicine, University of Washington, Seattle, WA;
Michael BoeckhVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Medicine, and.ORCID http://orcid.org/0000-0003-1538-7984
Infectious Disease Research Institute · USUniversity of California, San Francisco · USFred Hutch Cancer Center · USUniversity of Washington · USSamsung Medical Center · KRUniversité de Montréal · CA

Funding

VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Geoffrey Roger HILL · 1985 to 2026
$128.4M
Respiratory Viruses and Airflow Obstruction after HCTR01HL081595 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOECKH, MICHAEL J · 2005 to 2008
$2.5M
Infections in Hematopoietic Cell Transplant RecipientsK24HL093294 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOECKH, MICHAEL J · 2009 to 2019
$1.5M
NCI NIH HHS CA18029NCI NIH HHS P01 CA018029NHLBI NIH HHS HL081595NHLBI NIH HHS K24 HL093294NHLBI NIH HHS K24HL093294NHLBI NIH HHS R01 HL081595
6 · The paper itself

Abstract

Newer diagnostic methods may link more idiopathic pneumonia syndrome (IPS) cases to an infectious agent. Bronchoalveolar lavage (BAL) samples from 69 hematopoietic cell transplant (HCT) recipients with IPS diagnosed between 1992 and 2006 were tested for 28 pathogens (3 bacteria and 25 viruses) by quantitative polymerase chain reaction and for Aspergillus by galactomannan assay. Research BALs from 21 asymptomatic HCT patients served as controls. Among 69 HCT patients with IPS, 39 (56.5%) had a pathogen detected. The most frequent pathogens were human herpesvirus-6 (HHV-6) (N = 20 [29%]) followed by human rhinovirus (HRV), cytomegalovirus (CMV), and Aspergillus (N = 8 [12%] in each). HHV-6 and HRV were rarely detected in controls, whereas CMV and Aspergillus were occasionally detected with low pathogen load. Patients with pathogens had worse day-100 survival than those without (hazard ratio, 1.88; P = .03). Mortality in patients with only pathogens of "uncertain" significance in lung was similar to that in patients with pathogens of "established" significance. Metagenomic next-generation sequencing did not reveal additional significant pathogens. Our study demonstrated that approximately half of patients with IPS had pathogens detected in BAL, and pathogen detection was associated with increased mortality. Thus, an expanded infection detection panel can significantly increase the diagnostic precision for idiopathic pneumonia.

Indexed as

AdolescentAdultAspergillosisAspergillusBacterial InfectionsBronchoalveolar Lavage FluidChildCohort StudiesFemaleHematopoietic Stem Cell TransplantationHumansLungLung InjuryMaleMiddle AgedVirus Diseases

Identifiers

PMID25918347
PMCPMC4463739
OpenAlexW2001595227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.